Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,998 | 506 | 99.2% |
| Education | $56.92 | 6 | 0.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $1,129 | 112 | $0 (2024) |
| ABBVIE INC. | $901.64 | 48 | $0 (2024) |
| Novo Nordisk Inc | $794.43 | 65 | $0 (2024) |
| Amgen Inc. | $784.64 | 59 | $0 (2024) |
| Astellas Pharma US Inc | $479.01 | 23 | $0 (2023) |
| Lilly USA, LLC | $355.15 | 24 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $319.86 | 23 | $0 (2024) |
| GlaxoSmithKline, LLC. | $287.17 | 20 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $282.88 | 18 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $195.29 | 16 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,300 | 88 | PFIZER INC. ($278.93) |
| 2023 | $1,380 | 103 | AbbVie Inc. ($355.37) |
| 2022 | $1,115 | 76 | ABBVIE INC. ($269.30) |
| 2021 | $303.64 | 18 | Astellas Pharma US Inc ($68.05) |
| 2020 | $252.22 | 16 | Astellas Pharma US Inc ($40.06) |
| 2019 | $902.17 | 69 | PFIZER INC. ($175.78) |
| 2018 | $854.77 | 68 | PFIZER INC. ($235.12) |
| 2017 | $947.13 | 74 | Astellas Pharma US Inc ($167.85) |
All Payment Transactions
512 individual payment records from CMS Open Payments — Page 1 of 21
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $15.05 | General |
| Category: PAIN | ||||||
| 12/16/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $15.03 | General |
| Category: PAIN | ||||||
| 12/10/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $15.86 | General |
| Category: PAIN | ||||||
| 12/09/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $15.15 | General |
| Category: PSYCHIATRY | ||||||
| 12/04/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $14.99 | General |
| Category: Bone Health | ||||||
| 11/19/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $13.91 | General |
| Category: Diabetes | ||||||
| 11/14/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $13.27 | General |
| Category: Respiratory | ||||||
| 11/14/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $12.25 | General |
| Category: PAIN | ||||||
| 11/07/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $14.15 | General |
| Category: Diabetes | ||||||
| 11/06/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $14.09 | General |
| Category: Diabetes | ||||||
| 11/04/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $12.52 | General |
| Category: NEUROSCIENCE | ||||||
| 10/31/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.20 | General |
| Category: NEUROSCIENCE | ||||||
| 10/29/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $16.07 | General |
| Category: Diabetes | ||||||
| 10/28/2024 | Edwards Lifesciences Corporation | Edwards SAPIEN 3 Ultra Transcatheter Heart Valve (Device) | Food and Beverage | In-kind items and services | $23.40 | General |
| Category: Transcatheter Heart Valves | ||||||
| 10/23/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $15.06 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/21/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $14.96 | General |
| Category: VACCINES | ||||||
| 10/15/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.07 | General |
| Category: Diabetes | ||||||
| 10/08/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $13.92 | General |
| Category: PAIN | ||||||
| 10/07/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $12.62 | General |
| Category: Inflammation | ||||||
| 09/27/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $19.33 | General |
| Category: Respiratory | ||||||
| 09/26/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $21.53 | General |
| Category: Bone Health | ||||||
| 09/19/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $24.44 | General |
| Category: Endocrinology | ||||||
| 09/17/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $16.19 | General |
| Category: Inflammation | ||||||
| 09/12/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $11.08 | General |
| Category: PAIN | ||||||
| 09/09/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $14.33 | General |
| Category: PSYCHIATRY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 27 | 2,868 | 3,678 | $315,326 | $136,353 |
| 2022 | 31 | 2,956 | 4,760 | $348,327 | $158,519 |
| 2021 | 33 | 3,244 | 5,780 | $379,597 | $171,307 |
| 2020 | 24 | 2,485 | 5,169 | $335,607 | $129,086 |
All Medicare Procedures & Services
115 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 296 | 544 | $116,960 | $39,510 | 33.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 242 | 242 | $42,108 | $29,340 | 69.7% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 35 | 35 | $20,055 | $9,901 | 49.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 155 | 214 | $32,100 | $9,683 | 30.2% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 109 | 109 | $12,535 | $7,751 | 61.8% |
| 91320 | Sarscv2 vac 30mcg trs-suc im | Office | 2023 | 44 | 44 | $12,672 | $5,525 | 43.6% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 270 | 348 | $14,268 | $4,514 | 31.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 317 | 534 | $5,340 | $4,463 | 83.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 120 | 120 | $4,440 | $3,587 | 80.8% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 161 | 204 | $9,792 | $3,358 | 34.3% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 190 | 190 | $5,130 | $3,209 | 62.6% |
| 80048 | Blood test, basic group of blood chemicals (calcium, total) | Office | 2023 | 237 | 300 | $7,200 | $2,480 | 34.4% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 14 | 14 | $4,284 | $2,185 | 51.0% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 154 | 215 | $6,450 | $2,022 | 31.3% |
| 90480 | Admn sarscov2 vacc 1 dose | Office | 2023 | 44 | 44 | $2,552 | $1,712 | 67.1% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 147 | 150 | $4,800 | $1,545 | 32.2% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 153 | 178 | $4,272 | $1,342 | 31.4% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 40 | 40 | $1,720 | $1,196 | 69.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 14 | 14 | $2,646 | $744.32 | 28.1% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 14 | 17 | $1,666 | $580.80 | 34.9% |
| 83880 | Natriuretic peptide (heart and blood vessel protein) level | Office | 2023 | 13 | 13 | $1,222 | $500.11 | 40.9% |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | Office | 2023 | 24 | 24 | $1,248 | $454.08 | 36.4% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2023 | 17 | 19 | $817.00 | $280.82 | 34.4% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2023 | 13 | 13 | $429.00 | $261.99 | 61.1% |
| 82043 | Urine microalbumin (protein) level | Office | 2023 | 12 | 13 | $208.00 | $73.58 | 35.4% |
About Dr. Saira Babar, M.D
Dr. Saira Babar, M.D is a Family Medicine healthcare provider based in Jefferson City, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/21/2005. The National Provider Identifier (NPI) number assigned to this provider is 1306822317.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Saira Babar, M.D has received a total of $7,055 in payments from pharmaceutical and medical device companies, with $1,300 received in 2024. These payments were reported across 512 transactions from 46 companies. The most common payment nature is "Food and Beverage" ($6,998).
As a Medicare-enrolled provider, Babar has provided services to 11,553 Medicare beneficiaries, totaling 19,387 services with total Medicare billing of $595,264. Data is available for 4 years (2020–2023), covering 115 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Other Specialties Emergency Medicine
- Location Jefferson City, MO
- Active Since 12/21/2005
- Last Updated 12/01/2009
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1306822317
Products in Payments
- UBRELVY (Drug) $425.94
- NURTEC ODT (Drug) $420.24
- QULIPTA (Drug) $347.45
- Ozempic (Drug) $255.07
- EVENITY (Biological) $254.63
- Myrbetriq (Drug) $240.49
- ELIQUIS (Drug) $236.20
- Otezla (Drug) $225.32
- SHINGRIX (Biological) $209.30
- FARXIGA (Drug) $209.03
- Rybelsus (Drug) $208.34
- CHANTIX (Drug) $207.29
- Prolia (Biological) $177.85
- LYRICA (Drug) $173.55
- JARDIANCE (Drug) $160.65
- VRAYLAR (Drug) $144.34
- COMIRNATY (Biological) $139.15
- MYRBETRIQ (Drug) $133.82
- MOUNJARO (Drug) $130.06
- XARELTO (Drug) $127.66
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Jefferson City
Dr. George Carr, Md, MD
Family Medicine — Payments: $45,033
Dr. Eric Caywood, D.o, D.O
Family Medicine — Payments: $17,382
Dustin Warbritton, D.o, D.O
Family Medicine — Payments: $13,272
Benjamin Cook, Do, DO
Family Medicine — Payments: $9,154
Dr. Michael Steenbergen, M.d, M.D
Family Medicine — Payments: $9,039
Dr. Joseph Rakestraw, D.o, D.O
Family Medicine — Payments: $6,457